These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33534525)

  • 1. Association Between Treatment of Secondary Hyperparathyroidism and Posttransplant Outcomes.
    Mathur A; Sutton W; Ahn JB; Prescott JD; Zeiger MA; Segev DL; McAdams-DeMarco M
    Transplantation; 2021 Dec; 105(12):e366-e374. PubMed ID: 33534525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Secondary Hyperparathyroidism and Posttransplant Tertiary Hyperparathyroidism.
    Egan CE; Qazi M; Lee J; Lee-Saxton YJ; Greenberg JA; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    J Surg Res; 2023 Nov; 291():330-335. PubMed ID: 37506432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hypercalcemic Hyperparathyroidism After Kidney Transplantation Is Associated With Improved Allograft Survival.
    Wang R; Reed RD; Price G; Abraham P; Lewis M; McMullin JL; MacLennan P; Killian C; Locke JE; Ong S; Kumar V; Gillis A; Lindeman B; Chen H; Fazendin J
    Oncologist; 2024 Apr; 29(4):e467-e474. PubMed ID: 38006197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroidectomy and Cinacalcet Use in Medicare-Insured Kidney Transplant Recipients.
    Wang AX; Liu S; Montez-Rath ME; Chertow GM; Lenihan CR
    Am J Kidney Dis; 2023 Mar; 81(3):270-280.e1. PubMed ID: 36162617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroidectomy versus oral cinacalcet on cardiovascular parameters in peritoneal dialysis patients with advanced secondary hyperparathyroidism (PROCEED): a randomized trial.
    Wang AY; Lo WK; Cheung SC; Tang TK; Yau YY; Lang BH
    Nephrol Dial Transplant; 2023 Jul; 38(8):1823-1835. PubMed ID: 36869794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia.
    Mathur A; Ahn JB; Sutton W; Chu NM; Gross AL; Segev DL; McAdams-DeMarco M
    Nephrol Dial Transplant; 2022 Oct; 37(11):2111-2118. PubMed ID: 35512551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage.
    Mathur A; Ahn JB; Sutton W; Zeiger MA; Segev DL; McAdams-DeMarco M
    Surgery; 2022 Jul; 172(1):118-126. PubMed ID: 35314072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Parathyroidectomy Versus Oral Cinacalcet on Bone Mineral Density in Patients on Peritoneal Dialysis With Advanced Secondary Hyperparathyroidism: The PROCEED Pilot Randomized Trial.
    Wang AY; Tang TK; Yau YY; Lo WK
    Am J Kidney Dis; 2024 Apr; 83(4):456-466.e1. PubMed ID: 38040277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
    Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
    Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trial.
    Parfrey PS; Chertow GM; Block GA; Correa-Rotter R; Drüeke TB; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC; Dehmel B; Trotman ML; Modafferi DM; Goodman WG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4834-44. PubMed ID: 24108314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of parathyroidectomy versus cinacalcet in the clinical management of secondary hyperparathyroidism.
    Kim WW; Rhee Y; Kim BS; Kim K; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    Endocr J; 2019 Oct; 66(10):881-889. PubMed ID: 31189770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States.
    Fligor SC; Li C; Hamaguchi R; William J; James BC
    J Surg Res; 2021 Aug; 264():444-453. PubMed ID: 33848844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
    McManus C; Oh A; Lee JA; Hur C; Kuo JH
    Surgery; 2021 Jan; 169(1):94-101. PubMed ID: 32732069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis.
    Dulfer RR; Koh EY; van der Plas WY; Engelsman AF; van Dijkum EJMN; Pol RA; Vogt L; de Borst MH; Kruijff S; Schepers A; Appelman-Dijkstra NM; Rotmans JI; Hesselink DA; van Eijck CHJ; Hoorn EJ; van Ginhoven TM;
    Langenbecks Arch Surg; 2019 Feb; 404(1):71-79. PubMed ID: 30729318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].
    Jean G; Vanel T; Terrat JC; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Vovan C; Chazot C
    Nephrol Ther; 2010 Apr; 6(2):105-10. PubMed ID: 20185380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.
    Tominaga Y; Kakuta T; Yasunaga C; Nakamura M; Kadokura Y; Tahara H
    Ther Apher Dial; 2016 Feb; 20(1):6-11. PubMed ID: 26879490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcimimetics versus parathyroidectomy: What is preferable?
    Rroji M; Spasovski G
    Int Urol Nephrol; 2018 Jul; 50(7):1271-1275. PubMed ID: 29532306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroidectomy: still the best choice for the management of severe secondary hyperparathyroidism.
    Ramos LGF; Cortes DDPVR; Reis LMD; Montenegro FLM; Arap SS; Brescia MDG; Custódio MR; Jorgetti V; Elias RM; Moysés RMA
    J Bras Nefrol; 2024; 46(2):e20230024. PubMed ID: 38039492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.